More extensive enzyme phenotype data of SSA countries are necessary to comprehensively evaluate whether other differences might be significant (e.g., CYP3A4/5 enzyme phenotype frequencies across SSA).
← all excerpts
Building Sub-Saharan African PBPK Populations Reveals Critical Data Gaps: A Case Study on Aflatoxin B1.
1
—
—